Medical Condition News

RSS

CX3CL1 signaling chemical can offer better understanding of Parkinson's disease

Targeting the neuroinflammatory causes of Parkinson's disease with a naturally present brain chemical signal could offer a better understanding of the clinical mechanisms of the disease and open a future therapeutic window, reports a team of researchers from the University of South Florida Department Neurosurgery and Brain Repair and the James A. Haley Veterans' Administration Hospital, Tampa.

14 Feb 2011

Some fat is essential for body function

It's common knowledge that too much cholesterol and other fats can lead to disease, and that a healthy diet involves watching how much fatty food we eat. However, our bodies need a certain amount of fat to function—and we can't make it from scratch.

14 Feb 2011

Study explores levels of burden and depression in caregivers with sensory impairment

When a person experiences impairment or declining health, caregiving typically falls to a family member, most often a spouse. This increased burden can cause burnout, stress, and illness in the caregiver. The health care system focuses first on the client and provides little support for the caregiver.

14 Feb 2011

UH Case Stroke and Cerebrovascular Center increases tPA use for ischemic stroke by 13.5 times

University Hospitals Stroke and Cerebrovascular Center recently reported that it has increased the use of tPA or "clot busting therapy" for ischemic stroke by 13.5 times throughout UH system hospitals since implementing the System Stroke Program. Launched in 2008, SSP sought to increase access to the lifesaving treatment for acute ischemic stroke patients in the 15 counties surrounding Cleveland.

14 Feb 2011

New study establishes link between coronary artery disease and genetic susceptibility

A new study involving researchers at the Scripps Translational Science Institute and Scripps Health patients reveals major scientific progress in understanding the mechanism of heart disease at the molecular and genomic levels. STSI is an initiative of Scripps Health in collaboration with The Scripps Research Institute.

14 Feb 2011

SOC, UCLA present national stroke study data at 2011 International Stroke Conference

Specialists On Call, the nation's leading provider of clinical telemedicine services, announced today that it has presented data from a national stroke study conducted in partnership with the University of California at Los Angeles at the American Heart Association and American Stroke Association's International Stroke Conference.

14 Feb 2011

Positive results from LEAPS trial presented at International Stroke Conference in Los Angeles

One year after having a stroke, 52% of people who participate in either a physical therapy program that includes a walking program using a body-weight supported treadmill or a home-based program focused on progressive strength and balance exercises experience improved functional walking ability, according to the results of the Locomotor Experience Applied Post-stroke trial being presented today at the American Stroke Association's International Stroke Conference 2011 in Los Angeles.

14 Feb 2011

Two Uofl professors provide reference works in oncology field

Two University of Louisville School of Medicine professors recently authored reference works in the field of oncology, one focusing on the use of radiation treatment for childhood cancers and the other on hepatocellular carcinoma, or liver cancer.

14 Feb 2011

Last patient in EU Diamyd Phase III clinical study completes 15-month visit for type 1 diabetes

The last patient in the EU Diamyd Phase III clinical study has completed the 15-month visit, meaning that all patients in this study have completed the main 15 month study period in this trial. This important achievement in the Diamyd® Phase III program will now be followed by an intense period where the data will be compiled from the more than 60 clinics throughout Europe and from the central laboratory.

14 Feb 2011

New clinical trial to test surgery specifically for Type 2 diabetes

A new clinical trial at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is among the first to test surgery specifically for Type 2 diabetes. The aim of the study is to understand whether surgery can control diabetes, as well or even better than the best medical treatment available today. This is the first study of its kind open to patients who are overweight or mildly obese.

14 Feb 2011

Spinal cord sugar residues regulate growth and survival of nerve cells: Study

Researchers in Bochum have found out that certain sugar residues in the spinal cord regulate the growth and survival of nerve cells which control the movement of muscles. "We hope that our findings can improve regenerative treatment of nerve injuries", explains Prof. Dr. Stefan Wiese from the Molecular Cell Biology study group.

14 Feb 2011

The Lancet publishes CHAMPION trial results against heart failure

The CHAMPION clinical trial was published online today in The Lancet. CHAMPION demonstrated a 30% reduction in the primary efficacy endpoint of heart failure hospitalization rates at 6 months, and a 39% reduction in heart failure hospitalization rates at 15 months for heart failure patients whose treatment was guided by pulmonary artery pressures obtained through a miniature, wireless sensor, compared to control patients receiving standard heart failure treatment.

14 Feb 2011

FDA approves Hologic's 3-D digital mammography system to diagnose breast cancer

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the Company received approval from the U.S. Food and Drug Administration for its Selenia Dimensions digital breast tomosynthesis system.

From Hologic, Inc. 14 Feb 2011

JTH publishes positive TB-402 Phase II trial results for VTE treatment after orthopaedic surgery

ThromboGenics NV and co-development partner BioInvent International announce today that the positive TB-402 Phase II trial results, evaluating the product's efficacy and safety for the prevention of venous thromboembolism afterorthopaedic surgery, have been published in the Journal of Thrombosis and Haemostasis.

14 Feb 2011

Tiny gold particles can help doctors detect CTCs in blood of patients with head, neck cancer

Tiny gold particles can help doctors detect tumor cells circulating in the blood of patients with head and neck cancer, researchers at Emory and Georgia Tech have found.

14 Feb 2011

Children with ADHD may have greater risk of developing substance problems in adolescence, adulthood

Children with attention-deficit hyperactivity disorder are two to three times more likely than children without the disorder to develop serious substance abuse problems in adolescence and adulthood, according to a study by UCLA psychologists and colleagues at the University of South Carolina.

14 Feb 2011

Book explores association between physical activity and cancer control

Physical activity is an important health behaviour for many diseases but its role in cancer control has been understudied and underappreciated. This book, edited by Kerry S. Courneya and Christine M. Friedenreich, explores in depth the relation between physical activity and cancer control, including primary prevention, coping with treatments, recovery after treatments, long-term survivorship, secondary prevention, and survival.

14 Feb 2011

Researchers discover mechanism for normalizing blood sugar without insulin need

Diabetes can result from either a deficiency of insulin or decreased sensitivity to insulin. Researchers at Children's Hospital Boston have discovered a mechanism for normalizing blood sugar that doesn't involve insulin and could offer a new therapeutic approach to both kinds of diabetes.

14 Feb 2011

Selenia Dimensions System receives FDA approval for 3-D X-ray mammography device

The U.S. Food and Drug Administration today approved the Selenia Dimensions System, the first X-ray mammography device that provides three-dimensional images of the breast for breast cancer screening and diagnosis.

14 Feb 2011

UCLA study finds stroke, cardiovascular disease have exacted enormous toll on Hollywood stars

A study by researchers at the UCLA Stroke Center found that stroke and cardiovascular disease have exacted an enormous toll on Hollywood stars.

14 Feb 2011

Medical Condition News

CX3CL1 signaling chemical can offer better understanding of Parkinson's disease

Some fat is essential for body function

Study explores levels of burden and depression in caregivers with sensory impairment

UH Case Stroke and Cerebrovascular Center increases tPA use for ischemic stroke by 13.5 times

New study establishes link between coronary artery disease and genetic susceptibility

SOC, UCLA present national stroke study data at 2011 International Stroke Conference

Positive results from LEAPS trial presented at International Stroke Conference in Los Angeles

Two Uofl professors provide reference works in oncology field

Last patient in EU Diamyd Phase III clinical study completes 15-month visit for type 1 diabetes

New clinical trial to test surgery specifically for Type 2 diabetes

Spinal cord sugar residues regulate growth and survival of nerve cells: Study

The Lancet publishes CHAMPION trial results against heart failure

FDA approves Hologic's 3-D digital mammography system to diagnose breast cancer

JTH publishes positive TB-402 Phase II trial results for VTE treatment after orthopaedic surgery

Tiny gold particles can help doctors detect CTCs in blood of patients with head, neck cancer

Children with ADHD may have greater risk of developing substance problems in adolescence, adulthood

Book explores association between physical activity and cancer control

Researchers discover mechanism for normalizing blood sugar without insulin need

Selenia Dimensions System receives FDA approval for 3-D X-ray mammography device

UCLA study finds stroke, cardiovascular disease have exacted enormous toll on Hollywood stars

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News